Are you living with primary biliary cholangitis (PBC) and are taking or plan to take elafibranor for your condition? Consider joining our registry study to help advance treatment options and patient quality of life with this condition. We invite you to participate to discuss your experience and the impact on your condition seen with elafibranor. By joining, you'll contribute to understanding the effectiveness and safety of elafibranor in treating PBC. The study aims to evaluate its impact on itching, fatigue, sleep, and overall quality of life. Your participation is voluntary, and you can withdraw at any time without losing medical benefits. With approximately 424 participants globally, you'll continue to receive treatment as usual during the 5-year study period. Plus, you'll have opportunities to discuss your experience with our team and have your voice heard regarding your experience with elafibranor and it's effect on your quality of life with PBC.

If you have Autosomal Dominant Polycystic Kidney Disease (ADPKD), you can help us find out how a new investigational drug works for people like you. Joining this study might not help you directly, but it could help others in the future.

We're doing this study to explore how a device called TheraBionic affects people with liver cancer and their condition. This device uses special frequencies to target cancer cells and is being tested for treating advanced liver cancer.

Do you have a kidney transplant? Have you been diagnosed with recurrent Immunoglobulin A nephropathy (IgAN) or Focal Segmental Glomerulosclerosis (FSGS)? If so, this study may be of interest to you.

Have you been diagnosed with Metastatic Neuroendocrine Tumors or Pancreatic Cancer? If so then you may be a good fit for a clinical trial that evaluates the length of time cancer is not growing, or spreading) in participants when treated with zanzalintinib compared to everolimus.

Do you or your child have a kidney condition and take certain meds? Join our study and help us make a difference! You'll also get paid for your time.

Do you have protein in your urine and have had a kidney biopsy? You may be able to participate in a research study to test to see if a study drug can reduce the amount of protein in your urine.

A study to confirm the safety and effectiveness of a medication to help with alcohol-related liver disease in adults between 18 and 65 years old.

If you have protein in the urine and African descent, Hispanic or American Indian you might have a gene call APOL1 contributing kidney disease. This study will test if you have change in the gene. If you do have that change you can participate in this study .

Do you have lupus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopathy (IIM)? You may be eligible for a new CAR-T therapy conducted at University of North Carolina at Chapel Hill. Please reach out to learn more about this new innovative treatment.